Company / SG&A Expense
Astrana Health, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$217.3M
FY2025
5-year range
$62.1M / $217.3M
FY2021-FY2025
Trend
+41.0%
vs FY2024
Sector context
#103 of 158
Health Care
What the data says
At $217M, Astrana Health, Inc.'s sg&a expense ranks #56 of 158 in the Health Care sector. SG&A Expense has fluctuated over the past 10 years, ranging from $21M in FY2016 to $217M in FY2025.
Based on SEC 10-K filings.
$217M in FY2025 with a 5-year CAGR of +34.6%.
Increased from $62M to $217M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +40.9%
- 5-Year CAGR
- +34.6%
- 10-Year CAGR
- -
Sector benchmark
#56 of 158 in Health CareTop 35% of 158This company $217.3M Sector average $175.9B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +34.6%, indicating consistent growth.
- In FY2025, sg&a expense increased 41.0% year-over-year.
- Ranks #103 out of 158 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $217.3M | +41.0% |
| FY2024 | $154.1M | +148.3% |
| FY2023 | $62.1M | -20.1% |
| FY2022 | $77.7M | +25.1% |
| FY2021 | $62.1M | +26.4% |
| FY2020 | $49.1M | +18.4% |
| FY2019 | $41.5M | -4.3% |
| FY2018 | $43.4M | +65.2% |
| FY2017 | $26.2M | +24.8% |
| FY2016 | $21.0M | +24.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026